AlexandraS(Kazanovicz)BaileyMD

Oncology • Milford, MA

Clinical Fellow in Medicine, Beth Israel Deaconess Medical Center

Join to view full profile

Dr. Bailey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Bailey's full profile

Already have an account?

Office
20 Prospect Street
Milford, MA 01757
Phone+1 508-488-3700
Is this information wrong?

Education & Training

Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2008 - 2011
University of Massachusetts Medical SchoolClass of 2008

Certifications & Licensure

MA State Medical License 2010 - 2025
RI State Medical License 2022 - 2024
CA State Medical License 2022 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Supportive Care Mobile Application for Patients With NSCLC Start of enrollment: 2021 Oct 15
Active, not recruiting
Not Applicable
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

Care Fragmentation, Faulty Communication, and Documentation Lapses Derail a Treatment Plan.
Thomas J Roberts, Alexandra S Bailey, Naeem Tahir, Joseph O Jacobson> ;JCO Oncology Practice. 2023 Jan 1
Comprehensive Genomic Profiling Differentiates Metachronous Primary Small-Cell Lung Cancer From Late Recurrence.
Xin Gao, Paul A. VanderLaan, Alexandra S. Bailey, Daniel B. Costa> ;Clinical Lung Cancer. 2016 Sep 1
20 citations
Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma--Analysis Using Diagnostic Nodes.
Christian Rothermundt, Alexandra S. Bailey, Linda Cerbone, Tim Eisen, Bernard Escudier, Silke Gillessen, Viktor Grünwald, James Larkin, David F. McDermott, Jan Oldenbu...> ;The Oncologist. 2015 Sep 1
109 citations
The high-dose aldesleukin "select" trial: a trial to prospectively validate predictive models of response to treatment in patients with metastatic renal cell carcinoma.
David F. McDermott, Su Chun Cheng, Sabina Signoretti, Kim Margolin, Joseph I. Clark, Jeffrey A. Sosman, Janice P. Dutcher, Theodore F. Logan, Brendan D. Curti, Marc S....> ;Clinical Cancer Research. 2015 Feb 1
16 citations
Immune checkpoint inhibitors as novel targets for renal cell carcinoma therapeutics.
Alexandra S. Bailey, David F. McDermott> ;Cancer Journal. 2013 Jul 1
155 citations
Compound EGFR mutations and response to EGFR tyrosine kinase inhibitors.
Susumu Kobayashi, Hannah M. Canepa, Alexandra S. Bailey, Sohei Nakayama, Norihiro Yamaguchi, Michael A. Goldstein, Mark S. Huberman, Daniel B. Costa> ;Journal of Thoracic Oncology. 2013 Jan 1
Join now to see all

Hospital Affiliations

Dana-Farber Cancer InstituteBoston, Massachusetts
Brigham and Women's HospitalBoston, Massachusetts

AlexandraS(Kazanovicz)BaileyMD

Dr. Bailey is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.